Chimica Oggi/Chemistry Today ; 40(1):50-51, 2022.
Article in English | Scopus | ID: covidwho-2229374
Brazil produces only 5% of the active pharmaceutical ingredients needed to the manufacture of medicines. Recent changes on regulations and the COVID-19 pandemic could open the Brazilian market to a new window of opportunity where continuous manufacturing can play an important role to secure pharmaceutical supply chain. © 2022 TeknoScienze. All rights reserved.